Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1294594.RAiDYphFGL7VOYhQQyCBxQfFBmvVSLIoK_uLnF0SXI1sE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1294594.RAiDYphFGL7VOYhQQyCBxQfFBmvVSLIoK_uLnF0SXI1sE130_assertion type Assertion NP1294594.RAiDYphFGL7VOYhQQyCBxQfFBmvVSLIoK_uLnF0SXI1sE130_head.
- NP1294594.RAiDYphFGL7VOYhQQyCBxQfFBmvVSLIoK_uLnF0SXI1sE130_assertion description "[The correlation between ERCC1 polymorphisms (rs11615 and rs3212986) and XPD polymorphisms (rs13181 and rs1799793) with the response rate and overall survival of cancer patients who accept neoadjuvant therapy has been extensively investigated.However, the results are inconclusive.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294594.RAiDYphFGL7VOYhQQyCBxQfFBmvVSLIoK_uLnF0SXI1sE130_provenance.
- NP1294594.RAiDYphFGL7VOYhQQyCBxQfFBmvVSLIoK_uLnF0SXI1sE130_assertion evidence source_evidence_literature NP1294594.RAiDYphFGL7VOYhQQyCBxQfFBmvVSLIoK_uLnF0SXI1sE130_provenance.
- NP1294594.RAiDYphFGL7VOYhQQyCBxQfFBmvVSLIoK_uLnF0SXI1sE130_assertion SIO_000772 26426637 NP1294594.RAiDYphFGL7VOYhQQyCBxQfFBmvVSLIoK_uLnF0SXI1sE130_provenance.
- NP1294594.RAiDYphFGL7VOYhQQyCBxQfFBmvVSLIoK_uLnF0SXI1sE130_assertion wasDerivedFrom befree-2016 NP1294594.RAiDYphFGL7VOYhQQyCBxQfFBmvVSLIoK_uLnF0SXI1sE130_provenance.
- NP1294594.RAiDYphFGL7VOYhQQyCBxQfFBmvVSLIoK_uLnF0SXI1sE130_assertion wasGeneratedBy ECO_0000203 NP1294594.RAiDYphFGL7VOYhQQyCBxQfFBmvVSLIoK_uLnF0SXI1sE130_provenance.